CSCs that highly express CD133 (prominin-1) on cellular membrane isolated from both clinical specimens of lung cancer patients and human lung cancer cells have been documented to be mediators of drug resistance and tumor initiation properties [13, 14]. This evidence concerns the gene PROM1 and lung cancer.